HighTower Advisors’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding QGEN
HighTower Advisors's QGEN Position: Q2 2026 in Review
HighTower Advisors increased its Qiagen (QGEN) stake by 15% in Q2 2026, buying an estimated $49.2K and bringing the position to 10,236 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #2947.
HighTower Advisors first reported a position in QGEN in Q2 2018 and has held it in 25 quarters since. The position peaked at $1.38M in Q1 2019. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.
- HighTower Advisors held 10,236 shares of Qiagen worth $400K as of Q2 2026.
- HighTower Advisors bought 1,326 Qiagen shares in Q2 2026, an estimated $49.2K.
- Qiagen made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2947 holding.
- HighTower Advisors first reported a position in Qiagen in Q2 2018 and has held it in 25 quarters since.
- HighTower Advisors's Qiagen position peaked at $1.38M in Q1 2019.
- 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.